Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

443
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
443
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

520
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
520
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

346
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
346
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

347
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
347
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

554
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
554
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

773
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
773

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conduction system pacing in TAVR patients requiring permanent pacemaker implantation.

Heart rhythm·2026
Same author

Hypoattenuated Leaflet Thickening After TAVR: Incidence, Predictors, and the Role of Platelet Reactivity: A Prospective Multicenter Observational Study.

Journal of clinical medicine·2026
Same author

Contrast use and radiation exposure during transcatheter aortic valve implantation according to valve design.

Kardiologia polska·2026
Same author

Mitral Valve Leaflet Modification: A Working Group Position Statement on Best Practices and Step-by-Step Guide.

JACC. Cardiovascular interventions·2026
Same author

Balloon-Assisted Translocation of the Mitral Anterior Leaflet to Prevent Outflow Tract Obstruction During TMVR: The BATMAN Registry.

JACC. Cardiovascular interventions·2026
Same author

Leaflet Modification to Mitigate Coronary Obstruction Risk During TAVR: Results From the LOFTER-TAVR Registry.

JACC. Cardiovascular interventions·2026
Same journal

Optimizing Utilization and Minimizing Risk: The Next Era of Mechanical Circulatory Support Devices.

Interventional cardiology clinics·2026
Same journal

Foreword.

Interventional cardiology clinics·2026
Same journal

Future Directions in Temporary Mechanical Circulatory Support for Cardiogenic Shock: Novel Devices and Evolving Therapeutic Paradigms.

Interventional cardiology clinics·2026
Same journal

Prevention and Management of Acute Limb Ischemia when Using Temporary Mechanical Circulatory Support Devices.

Interventional cardiology clinics·2026
Same journal

Prevention and Management of Hemolysis when Utilizing Mechanical Circulatory Support.

Interventional cardiology clinics·2026
Same journal

Optimal Large-Bore Vascular Access and Closure for Percutaneous Mechanical Circulatory Support in Cardiogenic Shock.

Interventional cardiology clinics·2026
See all related articles

Related Experiment Video

Updated: Mar 1, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.4K

STEMI Interventions: The European Perspective and Stent for Life Initiative.

Ander Regueiro1, Javier Goicolea2, Antonio Fernández-Ortiz3

  • 1Stent for Life Initiative, Spanish Society of Cardiology, Nuestra Señora de Guadalupe, # 5-7, Madrid 28028, Spain; Cardiology Department, Thorax Institute, Hospital Clinic, c/Villarroel 170, Barcelona 08036, Spain.

Interventional Cardiology Clinics
|June 6, 2017
PubMed
Summary
This summary is machine-generated.

The Stent for Life Initiative aims to improve acute myocardial infarction treatment in Europe. It focuses on increasing access to primary percutaneous coronary intervention for ST-elevation myocardial infarction patients.

Keywords:
Acute myocardial infarctionNetworksPrimary angioplastyST segment elevationStent for life

More Related Videos

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

653
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.7K

Related Experiment Videos

Last Updated: Mar 1, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

26.4K
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

653
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.7K

Area of Science:

  • Cardiology
  • Public Health

Background:

  • Acute myocardial infarction (AMI) management guidelines exist.
  • Optimal treatment, specifically primary percutaneous coronary intervention (PCI), is not universally accessible to ST-segment elevation myocardial infarction (STEMI) patients in Europe.

Purpose of the Study:

  • To support the implementation of European Society of Cardiology (ESC) guidelines for AMI.
  • To identify barriers hindering guideline implementation.
  • To define actions ensuring widespread access to primary PCI for STEMI patients.

Main Methods:

  • The Stent for Life Initiative was established by the European Association of Percutaneous Cardiovascular Interventions and EuroPCR.
  • The initiative will define countries with unmet medical needs in STEMI treatment.
  • An action program will be implemented to enhance primary PCI access.

Main Results:

  • The initiative identifies specific European countries requiring improved STEMI treatment strategies.
  • It aims to bridge the gap between guideline recommendations and clinical practice for STEMI care.

Conclusions:

  • The Stent for Life Initiative is crucial for optimizing STEMI management across Europe.
  • Increased access to primary PCI is a key objective to improve outcomes for STEMI patients.